Study title: A multicentre, open label assessment of the safety of flavoured non-CFC propellant (HFA-227) Formulation of necrodomil sodium 4 mg QID via metered dose inhaler over 40 weeks in adolescent and adult asthmatics - Claire Cutts et al. - 16/10/1996
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NEDOCROMIL | |||||
ATC code: S01GX04 | |||||
Document link: Nedocromil-Study 3.pdf | |||||
Document date: 2011-09-14 | |||||
Study number: CR 2519 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |